Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Inflammatory Bowel Diseases|September 3, 2025
Functional Profiling Demonstrates That a Sulfide-Reducing Diet Achieves Microenvironmental Targets in Ulcerative ColitisAlice S Day, Rachael Slater, Remy B Young, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2022
Review article: the future of microbiome-based therapeuticsEmily L Gulliver, Remy B Young, Michelle Chonwerawong, et al.
BMC Genomics|August 18, 2004
From biomedicine to natural history research: EST resources for ambystomatid salamandersSrikrishna Putta, Jeramiah J Smith, John A Walker, et al.
JAMA|January 16, 2019
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical TrialSamuel P Costello, Patrick A Hughes, Oliver Waters, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2025
Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal LoadingRyan M Mathias, Thomas M Goodsall, Claire E Parker, et al.
Journal of Crohn'S & Colitis|October 6, 2021
Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus StatementJohan F K F Ilvemark, Tawnya Hansen, Thomas M Goodsall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Reliability of Intestinal Ultrasound for Evaluating Crohn's Disease Activity Using Point-of-care and Central ReadingThomas M Goodsall, Yoon-Kyo An, Jane M Andrews, et al.
The Lancet. Gastroenterology & Hepatology|October 24, 2024
International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statementCathy Lu, Ryan Rosentreter, Claire E Parker, et al.
BMJ Open|July 20, 2024
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trialRobert D Little, Jo McKenzie, Ashish Srinivasan, et al.
BMJ Open Gastroenterology|February 20, 2026
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trialVipul Jairath, Sudheer K Vuyyuru, Guangyong Zou, et al.
Pageof 20